第三条 公司聘请独立董事的人数应符合公司章程的规定，独立董事占董事会成员 的比例不得低于三分之一，且至少包括一名会计专业人士。（本条所称会计专业人士系指 具备较丰富的会计专业知识和经验，并至少符合下列条件之一：（一）具有注册会计师资 格；（二）具有会计、审计或者财务管理专业的高级职称、副教授及以上职称或者博士学 位；（三）具有经济管理方面高级职称，且在会计、审计或者财务管理等专业岗位有 5 年 以上全职工作经验。） 独立董事出现不符合独立性条件或其他不适宜履行独立董事职责的情形，由此造成 公司独立董事达不到公司章程或《上市公司独立董事管理办法》要求的人数时，应按规 定补足。 华峰化学股份有限公司 独立董事工作制度 第一章 总则 第一条 为进一步完善华峰化学股份有限公司（以下简称公司）的法人治理结构， 促进公司的规范运作，改善董事会结构，强化对内部董事及经理层的约束和监督机制， 保护中小股东及利益相关者的利益，根据《中华人民共和国公司法》《中华人民共和国证 券法》《上市公司独立董事管理办法》以及公司章程等相关规定，特制定本制度。 第二条 独立董事是指不在公司担任除董事外的其他职务，并与公司及其主要股东、 实际控 ...

华峰化学股份有限公司 内控审计报告 截至 2023 年 12 月 31 日 内部控制审计报告 信会师报字[2024]第 ZF10262 号 华峰化学股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相 关要求，我们审计了华峰化学股份有限公司（以下简称"华峰化学"） 2023 年 12 月 31 日的财务报告内部控制的有效性。 一、 企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、 《企业内部控制评价指引》的规定，建立健全和有效实施内部控制， 并评价其有效性是华峰化学董事会的责任。 二、 注册会计师的责任 我们的责任是在实施审计工作的基础上，对财务报告内部控制的 有效性发表审计意见，并对注意到的非财务报告内部控制的重大缺陷 进行披露。 内控审计报告1 第 1 页 四、 财务报告内部控制审计意见 我们认为，华峰化学于 2023 年 12 月 31 日按照《企业内部控制 基本规范》和相关规定在所有重大方面保持了有效的财务报告内部控 制。 三、 内部控制的固有局限性 内部控制具有固有局限性，存在不能防止和发现错报的可能性。 此外，由于情况的变化可能导致内部控制 ...

Financial Performance - The company's operating revenue for 2023 was ¥26,298,460,757.62, representing a 1.60% increase compared to ¥25,884,105,588.87 in 2022[20]. - The net profit attributable to shareholders for 2023 was ¥2,478,464,429.72, a decrease of 12.85% from ¥2,843,971,840.67 in 2022[20]. - The basic earnings per share for 2023 was ¥0.5000, a decline of 13.79% from ¥0.5800 in 2022[20]. - The company's total revenue for 2023 reached ¥26.30 billion, a 1.60% increase from ¥25.88 billion in 2022[59]. - The industrial segment contributed ¥26.28 billion, accounting for 99.94% of total revenue, with a 1.63% year-over-year growth[59]. - The company reported a total revenue of 5,080,309 million for the year, with a significant increase in sales from its subsidiaries[100]. - The company reported a total revenue of 6.77 billion yuan for the fiscal year 2023, reflecting a year-on-year increase of 12%[131]. - The company has set a revenue guidance of 7.5 billion yuan for the next fiscal year, indicating an expected growth of approximately 10%[131]. Production and Capacity - The company reported a total of 93.5 thousand tons of spandex production in 2023, an increase of 18.9% year-on-year[30]. - The company achieved a production capacity utilization rate of 104.49% for spandex, with a designed capacity of 32.5 thousand tons and an additional 20 thousand tons currently in trial production since April 2023[48]. - The production capacity utilization rate for adipic acid was 77.16%, with a designed capacity of 135.5 thousand tons, and 40 thousand tons currently in trial production since September 2023[48]. - The company plans to invest in a project to build an annual production capacity of 120,000 tons of PTMEG, enhancing its industrial chain[145]. - The company aims to achieve a 10% increase in overall production capacity by the end of 2024[175]. Research and Development - The company has a dedicated research and development team focused on new materials and technologies[19]. - The company has a total of 276 valid patents, including 210 invention patents, 63 utility model patents, and 3 design patents, with nearly 100 invention patents currently under application[51]. - The company is focusing on developing biodegradable thermoplastic polyether elastomers to meet the growing demand for environmentally friendly products[73]. - The company is investing 200 million yuan in R&D for new technologies aimed at enhancing production efficiency[131]. - The company has completed the development of a high-transparency polyurethane for shoe soles, enhancing market competitiveness[71]. Market and Sales - The company has established a comprehensive domestic and international sales network, serving over 20 countries and regions globally[36]. - Domestic sales accounted for 86.31% of total revenue, increasing by 3.11% year-over-year, while international sales decreased by 6.98% to 13.69%[60]. - The company is focusing on expanding its market presence and enhancing its product offerings, particularly in the polyurethane sector, which has shown significant growth potential[127]. - The company is actively pursuing strategic partnerships and collaborations to enhance its competitive edge in the market[127]. Risk Management - The company emphasizes the importance of risk awareness regarding market fluctuations, industry cycles, and raw material price volatility[4]. - The company has acknowledged the potential risks associated with forward-looking statements in its annual report[4]. - The company faces risks related to raw material price fluctuations, which could significantly affect profitability if not managed properly[103]. - The company emphasizes the importance of risk management and organizational restructuring to adapt to its expanding business scale[105]. Environmental Compliance - The company has a strong focus on environmental compliance, holding various permits and licenses related to pollution control and emergency response[50]. - The company achieved a total pollutant discharge of 15.88 tons/year, with no exceedance of the emission standards[172]. - The company has implemented a comprehensive waste management strategy to minimize environmental impact, including the treatment of VOCs through advanced technologies[181]. - The company’s wastewater is collected and treated before being discharged into the local river, ensuring compliance with environmental regulations[182]. Governance and Management - The company strictly adheres to the requirements of the Company Law and other relevant regulations, ensuring effective governance and protecting shareholder rights[111]. - The management team possesses extensive industry experience, contributing to effective strategic execution and operational management[54]. - The company has established a transparent performance evaluation and incentive mechanism for its directors and managers, promoting accountability[116]. - The company has maintained its board structure without changes throughout the reporting period[142]. Shareholder Returns - The company reported a cash dividend distribution plan of 1.5 RMB per 10 shares, totaling RMB 744,381,584.55, based on a total share capital of 4,962,543,897 shares[155]. - The total distributable profit for the period is RMB 1,640,979,436.58, with the cash dividend representing 100% of the profit distribution[154]. - The company has established a shareholder return plan for the next three years (2021-2023), focusing on sustainable development and balancing short-term and long-term shareholder interests[153]. Strategic Initiatives - The company aims to enhance its brand influence and market expansion as part of its strategic focus for the upcoming year[102]. - The company plans to implement a strategy of "seizing the market, ensuring quality, and reducing costs" to drive operational efficiency[102]. - The company is committed to innovation and technological upgrades to support its growth objectives[102]. - The company is exploring potential mergers and acquisitions to bolster its competitive position in the market[175].

证券代码：002064 证券简称：华峰化学 公告编号：2024-001 华峰化学股份有限公司 关于对外投资进展的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、对外投资情况概述 华峰化学股份有限公司（以下简称"公司"或"华峰化学"）第八届董事 会第十五次会议，审议通过了《关于投资建设年产 12 万吨 PTMEG 氨纶产业链 深化项目的议案》、《关于投资建设年产 110 万吨天然气一体化项目（一期）的 议案》，上述项目分别由公司全资子公司华峰重庆生物材料有限公司（以下简称 "重庆材料"）及重庆涪峰化工有限公司（以下简称"涪峰化工"）投资建设， 具体内容详见《关于投资建设氨纶产业链深化项目的公告》、《关于投资建设天 然气一体化项目的公告》，刊登于 2023 年 12 月 9 日《证券时报》《中国证券 报》《上海证券报》及巨潮资讯网（www.cninfo.com.cn）。 二、对外投资进展情况 近日，重庆材料、涪峰化工分别取得了由重庆市涪陵区规划和自然资源局 颁发的《中华人民共和国不动产权证书》（以下简称"不动产权证"），具体如 下： （一）重庆材料不动产 ...

现因葛绍政先生工作变动，为保证持续督导保荐工作的有序进行，东方投 行指定张仲先生接替葛绍政先生担任公司持续督导期间的保荐代表人，负责持 续督导工作，履行持续督导职责。 张仲先生简历如下： 张仲，现任东方证券承销保荐有限公司董事，保荐代表人,硕士研究生。曾 负责或参与长城搅拌IPO，开勒环境IPO，美晨科技IPO，双环传动IPO，纳尔股 份IPO，天常股份IPO，广誉远重大资产重组，美晨生态可转债等项目，具备良 好的业务素质和专业技能，丰富的公司改制、股权融资等投行业务实践经验。 本次保荐代表人变更后，华峰化学非公开发行股票并在深交所上市持续督 导保荐代表人为王震和张仲，持续督导期至中国证券监督管理委员会和深圳证 券交易所规定的持续督导义务结束为止。 证券代码：002064 证券简称：华峰化学 公告编号：2023-040 华峰化学股份有限公司 关于更换持续督导保荐代表人的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 华峰化学股份有限公司（以下简称"公司"）于 2023 年 12 月 26 日收到了 公司非公开发行股票的保荐机构东方证券承销保荐有限公司（以 ...

| 投资者关系活动 | √ 特定对象调研 □ 分析师会议 | | --- | --- | | 类别 | 媒体采访 业绩说明会 □ □ | | | 路演活动 □ 新闻发布会 □ | | | □ 现场参观 | | | □ 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 申万宏源、东北证券自营、中泰资管、招银理财、杭银理财、运 | | 人员姓名 | 舟资本、建兴保险资管、彬元资本 | | 时间 | 2023 年 12 月 15 日 | | 地点 | 公司会议室 | | 上市公司接待人 | 董秘李亿伦、证券专员朱格纬 | | 员姓名 | | | | 1.请问公司氨纶目前产能情况及后续是否有新的产能规划，投产 | | | 进度如何？ | | | 答：目前公司氨纶产能 32.5 万吨，后续还有 20 万吨产能尚在建 | | | 设中，预计 2025 年建设完成，公司将依据相关规则公告后续进 | | | 展。 | | | 2.请问目前氨纶行业盈利情况如何？ | | 投资者关系活动 | 答：今年氨纶行业在成本的强支撑及需求恢复有限的双压中博 | | 主要内容介绍 | 弈，市场供大于求，目前产品价格靠近历史底部窄 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记录、误导性陈述或重大遗漏。 证券代码：002064 证券简称：华峰化学 公告编号：2023-037 华峰化学股份有限公司 第八届董事会第十五次会议决议公告 （一）会议以 9 票赞成、0 票反对、0 票弃权，审议通过了《关于投资建设 年产 12 万吨 PTMEG 氨纶产业链深化项目的议案》，具体内容刊登于 2023 年 12 月 9 日 的 证 券 时 报 、 中 国 证 券 报 、 上 海 证 券 报 、 巨 潮 资 讯 网 （http://www.cninfo.com.cn）。 一、会议召开情况 华峰化学股份有限公司（以下简称"公司"）第八届董事会第十五次会议通 知于 2023 年 12 月 3 日以电子邮件或专人送达方式发出，会议于 2023 年 12 月 8 日以通讯表决的方式召开。会议由董事长杨从登先生主持，本次会议应到董事 9 人，实到 9 人。本次会议的召集、召开和表决程序符合《公司法》和《公司章程》 的有关规定，会议决议合法有效。 二、董事会会议审议情况 （二）会议以 9 票赞成、0 票反对、0 票弃权，审议通过了《关于投资建 ...

●特别风险提示：本项目的实施受多种因素影响，如因相关政府政策调整、 项目实施条件、市场环境等发生变化，项目也可能发生延期、变更、中止或无法 实施甚至终止。 一、项目概述 证券代码：002064 证券简称：华峰化学 公告编号：2023-039 华峰化学股份有限公司 关于投资建设天然气一体化项目的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 1.华峰化学股份有限公司（以下简称"公司"或"本公司"）第八届董事会 第十五次会议审议通过《关于投资建设年产 110 万吨天然气一体化项目（一期） 的议案》，拟通过全资子公司重庆涪峰化工有限公司（以下简称"涪峰化工"）投 资502,000万元建设年产110万吨天然气一体化项目（一期）（以下简称"项目"）。 本项目无需提交股东大会审议。公司将按照深圳证券交易所有关规定，及时披露 本项目的进展或变化情况，敬请投资者注意投资风险。 2.本次投资不构成关联交易，也不构成《上市公司重大资产重组管理办法》 规定的重大资产重组。 二、项目背景 年产 110 万吨天然气一体化项目（一期）的主要产品为 BDO，全称 1,4-丁二 醇,是 ...

证券代码：002064 证券简称：华峰化学 公告编号：2023-038 华峰化学股份有限公司 关于投资建设氨纶产业链深化项目的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 根据华瑞信息的相关报告，2022 年我国 PTMEG 年产量为 74.3 万吨，表观 消费量为 68.9 万吨，2023 年我国 PTMEG 年产量预计为 84.6 万吨，表观消费量 为 79.5 万吨。PTMEG 的下游应用领域包括氨纶、聚氨酯弹性体及酯醚共聚弹性 体，其中氨纶是我国 PTMEG 最大的消费领域，消化比例基本保持在 90%左右。 中国大陆氨纶产能 2022 年年末为 109.65 万吨，2023 年预计将达到 126.25 万吨， 因此对 PTMEG 的需求也不断增强。根据百川盈孚（国内知名大宗商品资讯提供 商）的预测，到 2025 年 PTMEG 市场总需求量约为 91.7 万吨。 ●特别风险提示：本项目的实施受多种因素影响，如因相关政府政策调整、 项目实施条件、市场环境等发生变化，项目也可能发生延期、变更、中止或无法 实施甚至终止。 一、项目概述 1.华峰化学股 ...

[Key Financial Data](index=2&type=section&id=Item%20I.%20Key%20Financial%20Data) [Key Accounting Data and Financial Indicators](index=2&type=section&id=Item%20(I).%20Key%20Accounting%20Data%20and%20Financial%20Indicators) In Q3 2023, the company reported a 15.67% YoY revenue increase and a 2,583.92% surge in net profit attributable to parent company shareholders, while year-to-date figures showed a slight revenue decline and a 20.17% decrease in net profit Key Accounting Data and Financial Indicators | Indicator | Q3 2023 (CNY) | Q3 YoY Change | YTD 2023 (CNY) | YTD YoY Change | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 7,059,850,370.51 | 15.67% | 19,681,919,713.06 | -1.30% | | Net Profit Attributable to Parent Company Shareholders | 569,893,076.20 | 2,583.92% | 1,928,532,126.31 | -20.17% | | Net Profit Attributable to Parent Company Shareholders (Excluding Non-Recurring Items) | 523,121,266.79 | 51,261.90% | 1,830,451,863.71 | -21.79% | | Basic Earnings Per Share (CNY/share) | 0.1148 | 2,569.77% | 0.39 | -22.00% | | Net Cash Flow from Operating Activities | - | - | 440,303,176.26 | -81.47% | | **Period-End Indicator** | **Sept 30, 2023 (CNY)** | **Change from Prior Year-End** | | | | Total Assets | 37,414,786,124.97 | 14.23% | | | | Total Equity Attributable to Parent Company Shareholders | 24,344,231,420.61 | 5.17% | | | [Non-Recurring Gains and Losses and Amounts](index=2&type=section&id=Item%20(II).%20Non-Recurring%20Gains%20and%20Losses%20and%20Amounts) Year-to-date, the company's total non-recurring gains and losses amounted to CNY 98.08 million, primarily driven by government grants recognized in current profit/loss totaling CNY 119 million Non-Recurring Gains and Losses | Item | Current Period Amount (CNY) | YTD Amount (CNY) | | :--- | :--- | :--- | | Gains/Losses on Disposal of Non-Current Assets | 85,024.17 | -2,860,185.24 | | Government Grants Recognized in Current Profit/Loss | 54,079,998.55 | 119,228,061.69 | | Other Non-Operating Income/Expenses and Investment Income | 964,016.66 | -983,958.32 | | Less: Impact of Income Tax and Minority Interests | 8,357,230.03 | 17,303,655.53 | | **Total** | **46,771,809.41** | **98,080,262.60** | [Changes and Reasons for Key Accounting Data and Financial Indicators](index=3&type=section&id=Item%20(III).%20Changes%20and%20Reasons%20for%20Key%20Accounting%20Data%20and%20Financial%20Indicators) During the reporting period, significant changes occurred in the company's balance sheet items, with construction in progress decreasing 60.50% due to conversion to fixed assets, which increased 40.83%; short-term borrowings surged 132.99% to support operations and projects, while net cash flow from operating activities declined 81.47% due to reduced sales collections and increased procurement - Asset-side changes primarily resulted from the completion and transfer of construction in progress to fixed assets[6](index=6&type=chunk) - **Construction in Progress**: -60.50% - **Fixed Assets**: +40.83% - Liability-side changes primarily stemmed from financing structure adjustments and increased borrowings[6](index=6&type=chunk) - **Short-term Borrowings**: +132.99% - **Non-Current Liabilities Due Within One Year**: +1445.37% (primarily long-term borrowings reclassified) - **Long-term Borrowings**: -67.68% - Net cash flow from operating activities significantly decreased by **81.47%** year-over-year, primarily due to reduced cash received from sales and increased cash paid for purchases[6](index=6&type=chunk) [Shareholder Information](index=4&type=section&id=Item%20II.%20Shareholder%20Information) [Common Shareholder Holdings](index=4&type=section&id=Item%20(I).%20Total%20Number%20of%20Common%20Shareholders%2C%20Number%20of%20Preferred%20Shareholders%20with%20Restored%20Voting%20Rights%20and%20Top%20Ten%20Shareholders%27%20Holdings) As of the reporting period end, the company had 69,606 common shareholders, with controlling shareholder Huafeng Group Co., Ltd. holding 45.10%; among the top ten shareholders, You Xiaoping, You Xiaohua, You Jinhuan, and Chen Linzhen have related party relationships, and multiple funds under Gaoyi Asset Management are also listed - The total number of common shareholders at the end of the reporting period was **69,606** accounts[7](index=7&type=chunk) Top Ten Shareholders' Holdings | Shareholder Name | Shareholder Type | Holding Percentage | Number of Shares Held | | :--- | :--- | :--- | :--- | | Huafeng Group Co., Ltd. | Domestic Non-State-Owned Legal Person | 45.10% | 2,237,942,524 | | You Xiaoping | Domestic Natural Person | 8.03% | 398,522,485 | | You Xiaohua | Domestic Natural Person | 6.58% | 326,774,912 | | You Jinhuan | Domestic Natural Person | 6.52% | 323,763,106 | | Hong Kong Securities Clearing Company Limited | Overseas Legal Person | 2.96% | 146,944,423 | - Controlling shareholder Huafeng Group has related party relationships with individual shareholders You Xiaoping, You Xiaohua, You Jinhuan, and Chen Linzhen[8](index=8&type=chunk) [Other Significant Matters](index=5&type=section&id=Item%20III.%20Other%20Significant%20Matters) [Other Significant Matters](index=5&type=section&id=Item%20III.%20Other%20Significant%20Matters) During the reporting period, the company achieved three key milestones: its controlling subsidiary Chongqing Chemical's 1.15 million tons/year adipic acid expansion project (Phase VI) commenced trial operation, the company plans to donate CNY 500 million for education between 2023-2026, and it completed a share repurchase of Chongqing Spandex - The company's controlling subsidiary, Chongqing Chemical, commenced trial operation of its 1.15 million tons/year adipic acid expansion project (Phase VI) in September[9](index=9&type=chunk) - The company plans to donate **CNY 500 million** in installments from 2023 to 2026 to the Zhejiang Ruian Middle School Education Development Foundation for establishing a public school[9](index=9&type=chunk) - The company repurchased a **4.34%** stake in Chongqing Spandex held by China Development Fund Co., Ltd[9](index=9&type=chunk) [Quarterly Financial Statements](index=5&type=section&id=Item%20IV.%20Quarterly%20Financial%20Statements) [Consolidated Balance Sheet](index=5&type=section&id=Item%201.%20Consolidated%20Balance%20Sheet) As of September 30, 2023, total assets reached **CNY 37.41 billion**, up 14.23% from the beginning of the year, primarily driven by non-current assets due to construction in progress conversion; total liabilities were **CNY 13.07 billion**, up 36.03% mainly from increased short-term borrowings, while total equity attributable to parent company shareholders grew 5.17% to **CNY 24.34 billion** Consolidated Balance Sheet | Item | Sept 30, 2023 (CNY) | Jan 1, 2023 (CNY) | Change | | :--- | :--- | :--- | :--- | | **Total Assets** | **37,414,786,124.97** | **32,754,768,551.67** | **+14.23%** | | Total Current Assets | 22,439,837,383.76 | 18,668,150,633.09 | +20.20% | | Total Non-Current Assets | 14,974,948,741.21 | 14,086,617,918.58 | +6.31% | | **Total Liabilities** | **13,069,067,165.28** | **9,607,374,082.85** | **+36.03%** | | Total Current Liabilities | 11,387,635,385.62 | 6,964,214,979.67 | +63.52% | | Total Non-Current Liabilities | 1,681,431,779.66 | 2,643,159,103.18 | -36.39% | | **Total Equity** | **24,345,718,959.69** | **23,147,394,468.82** | **+5.18%** | | Total Equity Attributable to Parent Company Shareholders | 24,344,231,420.61 | 23,147,001,673.40 | +5.17% | [Consolidated Income Statement (YTD)](index=8&type=section&id=Item%202.%20Consolidated%20Income%20Statement%20(YTD)) In the first three quarters of 2023, the company's operating revenue was **CNY 19.68 billion**, a slight 1.30% YoY decrease; operating profit declined 21.15% to **CNY 2.16 billion** due to higher cost growth, resulting in net profit attributable to parent company shareholders of **CNY 1.93 billion**, down 20.17% YoY, with basic EPS at **CNY 0.39** Consolidated Income Statement (YTD) | Item | Current Period Amount (CNY) | Prior Period Amount (CNY) | YoY Change | | :--- | :--- | :--- | :--- | | Total Operating Revenue | 19,681,919,713.06 | 19,940,844,772.21 | -1.30% | | Total Operating Costs | 17,675,954,352.54 | 17,237,156,961.82 | +2.55% | | Operating Profit | 2,163,466,485.58 | 2,743,715,663.07 | -21.15% | | Total Profit | 2,130,527,475.65 | 2,729,680,014.61 | -21.95% | | Net Profit Attributable to Parent Company Shareholders | 1,928,532,126.31 | 2,415,844,870.96 | -20.17% | | Basic Earnings Per Share (CNY/share) | 0.39 | 0.50 | -22.00% | [Consolidated Cash Flow Statement (YTD)](index=9&type=section&id=Item%203.%20Consolidated%20Cash%20Flow%20Statement%20(YTD)) In the first three quarters of 2023, net cash flow from operating activities was **CNY 440 million**, a significant 81.47% YoY decrease; investing activities resulted in a net outflow of **CNY 1.26 billion**, primarily for fixed asset acquisition, while financing activities generated a net inflow of **CNY 1.85 billion** from new borrowings, with cash and cash equivalents at period-end totaling **CNY 10.70 billion** Consolidated Cash Flow Statement (YTD) | Item | Current Period Amount (CNY) | Prior Period Amount (CNY) | YoY Change | | :--- | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 440,303,176.26 | 2,376,141,773.89 | -81.47% | | Net Cash Flow from Investing Activities | -1,263,503,364.39 | -1,634,282,685.38 | Not Applicable | | Net Cash Flow from Financing Activities | 1,848,206,021.79 | 2,594,907,779.55 | -28.77% | | Net Increase in Cash and Cash Equivalents | 1,002,400,626.66 | 3,345,311,333.13 | -70.04% |